v3.24.0.1
Consolidated Statements of Operations - USD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Income Statement [Abstract]    
Sales, net of returns and allowances $ 13,094,752 $ 5,023,072
Cost of sales 38,350,545 37,672,308
Gross loss (25,255,793) (32,649,236)
Operating expenses    
Selling, general and administrative 55,574,740 73,220,088
Research and development 24,467,933 23,213,540
Total operating expenses 80,042,673 96,433,628
Loss from operations (105,298,466) (129,082,864)
Interest expense, net (8,731,247) (1,837,882)
Other (loss) income (10,000,000) 13,646,528
Loss before income taxes (124,029,713) (117,274,218)
Benefit from income taxes (110,524) 0
Net loss $ (123,919,189) $ (117,274,218)
Net loss per share of common stock - basic (in usd per share) $ (0.60) $ (0.74)
Net loss per share of common stock - diluted (in usd per share) $ (0.60) $ (0.74)
Weighted average number of common shares outstanding - basic (in shares) 207,293,249 158,576,305
Weighted average number of common shares outstanding - diluted (in shares) 207,293,249 158,576,305

Source